Torrent Pharmaceuticals Q2 Results FY27: Net Profit Falls 9.64% To ₹534 Crore Despite 50.78% Revenue Growth
New Delhi, Oct 23: Torrent Pharmaceuticals on Friday reported a 9.64 per cent decline in consolidated net profit to Rs 534 crore in the September quarter of the current fiscal. The company had posted a consolidated net profit of Rs 591 crore in the corresponding period a year ago, Torrent Pharmaceuticals Ltd said in a regulatory filing. Total revenue from operations in the second quarter of the…
Torrent Pharmaceuticals disclosed its Q2 results for FY27 on Friday, revealing a 9.64% decrease in consolidated net profit to ₹534 crore. This figure marked a decline from the ₹591 crore profit reported in the same quarter last year. However, the company saw a significant surge in total revenue, with operations generating Rs 4,979 crore, a 50.78% increase from the ₹3,302 crore earned in the previous year's Q2.
This revenue growth was reflected in all major regions, with India revenue rising by 20% to ₹2,181 crore, US revenue increasing by 24% to ₹417 crore, Brazil revenue up 38% to ₹440 crore, and Germany revenue slightly declining by 7% to ₹283 crore.
Torrent's total expenses for the quarter amounted to Rs 4,222 crore, an increase from the ₹2,471 crore reported in the previous year's Q2. The company's India division accounted for a substantial portion of its earnings, with a 20% increase in revenue to ₹2,181 crore. Similarly, the US division witnessed a 24% rise in revenue to ₹417 crore.
Brazil revenue expanded by 38% to ₹440 crore, while Germany's revenue experienced a modest decline of 7% to ₹283 crore. For the first half of FY27, the company reported a consolidated net profit of ₹1,100 crore, a 3.42% decrease from the ₹1,139 crore profit reported in the same period of the previous fiscal year.
Written by urgent.news from Free Press Journal's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
